COVID-19

Testing Support

Molecular testing for the detection of SARS-CoV-2 in about 2 hours on the BD MAX^™ System and now available for the B.1.1.7 (Alpha) variant identification with new VIASURE SARS-CoV-2 Variant Real Time PCR Detection Kit for BD MAX^™!

*Saliva testing is available for VIASURE SARS-CoV-2 (N1+N2) Real Time PCR Detection Kit for BD MAX^™ and VIASURE SARS-CoV-2 Variant Real Time PCR Detection Kit for BD MAX^™

For Clinicians

BD supports you as patient needs evolve with an expanding portfolio of assays.

For Labs

BD is your trusted partner to provide versatile, integrated and scalable instrumentation.

Customer

Insights

Hear what some of our customers say about our integrated solutions

%

Increase in productivity with
BD cervical screening solution

More from Dr. Camilo Adem, Institut de Pathologie de Paris
thousand

Fewer culture plates needed each
year with BD MAX^™ System

More from Dr. Jean-Marc Rousée, BIO67
-

Hours to obtain results
with BD MAX^™ System

More from Dr. Michael Collins, Chesterfield Royal Hospital

Solutions

At BD, we provide integrated solutions of products and services that comprehensively and seamlessly support healthcare providers across care areas

Cervical Cancer
Gastrointestinal
Infections
Healthcare-Associated
Infections
Respiratory
Infections
Women’s Health
& STIs

570,000

women diagnosed/year¹

311,000

deaths/year¹

> 1.7 BILLION

people are affected by infectious
diarrhoea each year worldwide^2,3

2^nd leading cause

of the death in children
under 5 years of age^2,3

> 100 Million

patients are affected by HAIs
each year worldwide⁴

AMR

Antimicrobial resistance is a major
concern in relation to HAIs.

~ 1 Billion

cases of seasonal
influenza/year worldwide⁵

~ 3-5 Million

Severe cases/year⁵

> 1 MILLION STIs

are acquired every
day worldwide⁶

> 75% of women

experience at least one episode of
vaginitis/vaginosis in their lifetime⁷

Discover

our Assays

BD Life Sciences strives to be a leader in molecular infectious disease and cervical cancer testing by offering a wide variety of assays. These assays cover multiple syndromic areas with high levels of efficiency, accuracy and flexibility to improve outcomes for all.

Meet BD COR™ System

Uniquely designed to meet your evolving needs focusing on efficiency, flexibility and performance

Integrates and automates the complete molecular laboratory workflow from pre-analytical processing to diagnostic test result*.

*The BD COR™ MX module and all related assays are currently under development, not available for sale yet.

Meet BD MAX™ System

Expand your laboratory’s molecular testing potential

Fully-integrated, automated platform that performs nucleic acid extraction and real-time PCR providing results for up to 24 samples across multiple syndromes in less than 3 hours*.

*MDR-TB assay is < 4 hours

Meet BD Viper™ LT System

Your solution for HPV testing and extended genotyping

Minimises hands-on time, increases efficiency by fully automating HPV molecular testing, and reduces errors with ready-to-use reagents, all through a self-contained and integrated benchtop platform for low- to medium-volume labs

Meet BD PrepMate™ automated accessory

Precise specimen transfer directly from BD SurePath™ Collection Vials

Designed to reduce risk of contamination errors by precisely transferring a defined specimen volume directly from BD SurePath™ Liquid-based Pap Test collection vials to associated centrifuge tubes

Meet BD Totalys™ MultiProcessor

Designed to meet the needs of evolving cervical cancer screening

Reduces potential for errors by automating the proprietary BD SurePath™ Liquid-based Pap Test cell enrichment process (for cytology testing), and pre-or post-cytology aliquots (for molecular testing), as well as providing automated chain-of-custody checks

Meet BD Totalys™ SlidePrep

Full automation from preparation to staining*

Offers fully automated, discrete preparation and staining of slides, reducing risk of contamination, while ensuring sample match and chain of custody through automatic bar-code scanning

*When used with BD Totalys™ MultiProcessor

Meet BD FocalPoint™ GS Imaging System

Taking Pap testing to a different level

The combination of the BD SurePath™ Liquid-based Pap Test imaged on the BD FocalPoint™ GS Imaging System provides you with definitive and actionable test results.

AMR , antimicrobial resistance; Cdiff , Clostridioides difficile ; COVID-19 , coronavirus disease 2019; CPO , carbapenemase-producing organisms ; CT , Chlamydia trachomatis ; GC , Neisseria gonorrhoeae ; HAI , healthcare-associated infection; HPV , human papillomavirus; MDR , Multi-Drug Resistant/Resistance; MRSA , Methicillin-Resistant Staphylococcus aureus ; MTBC , Mycobacterium tuberculosis complex ; PCR , Polymerase Chain Reaction; RSV , respiratory syncytial virus; SARS-CoV-2 , severe acute respiratory syndrome coronavirus 2; STI , sexually transmitted infection; TB , tuberculosis; TV , Trichomonas vaginalis; VanR , vancomycin resistance

1. World Health Organization. Cervical cancer overview. Available at: https://www.who.int/cancer/prevention/diagnosis-screening/cervical-cancer/en . Accessed May 2020. 2. World Health Organization. Diarrhoeal disease Fact sheet. Available at: http://www.who.int/mediacentre/factsheets/fs330/en/ . Accessed May 2020. 3. Bartsch SM et al. PLoS ONE. 2016;11(4):e0151219. 4. World Health Organization. Health care without avoidable infections. Available at: https://apps.who.int/iris/bitstream/handle/10665/246235/WHO-HIS-SDS-2016.10-eng.pdf;jsessionid=C477D74DC9AF05C3BEA0474CF2C8B601?sequence=1 . Accessed February 2020. 5. World Health Organization. 8 Things to know about pandemic influenza. Available at: https://www.who.int/news-room/feature-stories/detail/8-things-to-know-about-pandemic-influenza . Accessed April 2020. 6. World Health Organization. Sexually transmitted infections. Available at https://www.who.int/news-room/fact-sheets/detail/sexually-transmitted-infections-(stis) . Accessed May 2020. 7. Workowski KA and Bolan GA. MMWR Recomm Rep. 2015;64(RR-03):1-137.